PipelinePharma Logo

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-070.1 manufacturers

Filters

Filters

Filters , active

Country of origin : Japan

Clear all

1 products found

pp-070.1

Tablets

Dossier type
US CTD
Dossier status
Under development
Country of origin
Japan
GMP approvals
FDA
Comments
Indication: Advanced or metastatic solid tumors with HER2 or HER3 abnormalities, including HER2-amplified or HER2-mutated cancers that have progressed on standard HER2-directed therapies. Clinical stage: Phase I/II clinical development. Modality: Small molecule (oral) Mechanism / Target: Irreversible covalent inhibitor of HER2 and HER3 signaling, designed to suppress downstream proliferative pathways in tumors dependent on HER2/HER3 activation. Route / form: Oral tablets Differentiation: A next-generation covalent HER2/HER3 inhibitor with potential to overcome resistance to existing HER2-targeted treatments; offers precision activity in HER2-altered tumors and may address patients who no longer respond to antibody-based HER2 therapies.
Manufacturer #38605

A research-driven pharma company developing therapies across oncology and other major diseases. It advances innovative medicines through global R&D and strategic alliances. The organization emphasizes high-quality manufacturing and patient impact.

 

 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.